Back

BCL-XL is essential for the protection from secondary anemia caused by radiation-induced fatal kidney damage

Brinkmann, K.; Waring, P.; Glaser, S.; Wimmer, V.; Nhu, D.; Whitehead, L.; Delbridge, A. R.; Lessene, G.; Herold, M.; Kelly, G. L.; Grabow, S.; Strasser, A.

2020-04-29 pharmacology and toxicology
10.1101/2020.04.28.055665 bioRxiv
Show abstract

Studies of gene-targeted mice identified the roles of the different pro-survival BCL-2 proteins during embryogenesis, but less is known about the roles of these proteins in adults, including in the response to cytotoxic stresses, such as treatment with anti-cancer agents. We investigated the role of BCL-XL in adult mice using a strategy where prior bone marrow transplantation allowed for loss of BCL-XL exclusively in non-hematopoietic tissues to prevent anemia caused by BCL-XL-deficiency in erythroid cells. Unexpectedly, the combination of total-body {gamma}-irradiation (TBI) and genetic loss of Bcl-x caused secondary anemia resulting from chronic renal failure due to apoptosis of renal tubular epithelium with secondary obstructive nephropathy. These findings identify a critical protective role of BCL-XL in the adult kidney and inform on the use of BCL-XL inhibitors in combinations with DNA damage-inducing drugs for cancer therapy. SummaryThe inducible loss of BCL-XL in all cells of adult mice causes primary anemia due to apoptosis of erythroid and megakaryocytic cell populations. In contrast {gamma}-radiation plus loss of BCL-XL in all cells except hematopoietic cells causes secondary anemia resulting from kidney damage.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Scientific Reports
3102 papers in training set
Top 2%
15.0%
2
Nature Communications
4913 papers in training set
Top 17%
10.3%
3
Cancer Letters
32 papers in training set
Top 0.1%
8.6%
4
PLOS ONE
4510 papers in training set
Top 21%
8.6%
5
Archives of Toxicology
14 papers in training set
Top 0.1%
6.5%
6
eLife
5422 papers in training set
Top 19%
4.4%
50% of probability mass above
7
Nucleic Acids Research
1128 papers in training set
Top 5%
3.7%
8
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 27%
2.1%
9
Cancers
200 papers in training set
Top 2%
2.1%
10
EMBO reports
136 papers in training set
Top 2%
1.9%
11
PLOS Genetics
756 papers in training set
Top 7%
1.9%
12
Frontiers in Genetics
197 papers in training set
Top 4%
1.8%
13
JCI Insight
241 papers in training set
Top 3%
1.8%
14
Cancer Research
116 papers in training set
Top 2%
1.7%
15
Science Advances
1098 papers in training set
Top 17%
1.7%
16
Communications Biology
886 papers in training set
Top 12%
1.4%
17
Blood Cancer Journal
11 papers in training set
Top 0.2%
1.3%
18
iScience
1063 papers in training set
Top 21%
1.3%
19
Developmental Biology
134 papers in training set
Top 2%
1.3%
20
Clinical and Translational Medicine
30 papers in training set
Top 0.7%
0.9%
21
Oncotarget
15 papers in training set
Top 0.3%
0.9%
22
Disease Models & Mechanisms
119 papers in training set
Top 2%
0.8%
23
International Journal of Radiation Oncology*Biology*Physics
21 papers in training set
Top 0.4%
0.8%
24
Oncogene
76 papers in training set
Top 2%
0.8%
25
Molecular Cancer Therapeutics
33 papers in training set
Top 0.6%
0.8%
26
Cells
232 papers in training set
Top 6%
0.8%
27
Neuro-Oncology
30 papers in training set
Top 0.8%
0.7%
28
Cell Death & Disease
126 papers in training set
Top 3%
0.7%
29
Mucosal Immunology
42 papers in training set
Top 0.4%
0.7%
30
Frontiers in Immunology
586 papers in training set
Top 9%
0.7%